Acute Lymphoblastic Leukemia Clinical Trials in Guangzhou, Guangdong
15 recruitingGuangzhou, Guangdong, China
Showing 1–15 of 15 trials
Recruiting
Phase 1Phase 2
A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL
B Cell Precursor Acute Lymphoblastic Leukemia
Amgen281 enrolled86 locationsNCT04521231
Recruiting
Phase 1Phase 2
A Clinical Study of MK-1045 (CN201) in People With Precursor B-cell Acute Lymphoblastic Leukemia (MK-1045-002)
Acute Lymphoblastic Leukemia
MSD R&D (China) Co., Ltd.203 enrolled11 locationsNCT05579132
Recruiting
Phase 1Phase 2
Study of YK012 in B-cell Acute Lymphoblastic Leukemia
B-cell Acute Lymphoblastic Leukemia
Excyte Biopharma Ltd46 enrolled12 locationsNCT06580301
Recruiting
Phase 3
Efficacy of Targeted Drugs Combined With Chemotherapy in the Treatment of T-ALL
Acute Lymphoblastic Leukemia
Nanfang Hospital, Southern Medical University154 enrolled1 locationNCT07203352
Recruiting
Phase 3
Newly-diagnosed Pediatric Ph-positive B-ALL Protocol
Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+)Childhood Leukemia, Acute Lymphoblastic
Institute of Hematology & Blood Diseases Hospital, China150 enrolled24 locationsNCT07152041
Recruiting
Phase 2Phase 3
Newly-diagnosed Pediatric T-cell ALL Protocol
Acute Lymphoblastic LeukemiaChildhood Leukemia, Acute LymphoblasticT Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
Institute of Hematology & Blood Diseases Hospital, China610 enrolled27 locationsNCT06855810
Recruiting
Phase 2Phase 3
Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol
Childhood Leukemia, Acute LymphoblasticB-cell Acute Lymphoblastic Leukemia (B-ALL)Acute Lymphoblastic Leukemia ALL
Institute of Hematology & Blood Diseases Hospital, China3,000 enrolled27 locationsNCT06882057
Recruiting
Phase 1Phase 2
A Study of CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric)
B-cell Acute Lymphoblastic Leukemia
Juventas Cell Therapy Ltd.47 enrolled9 locationsNCT05667506
Recruiting
Phase 2
Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia
Relapsed or Refractory Acute Lymphoblastic Leukemia
Juventas Cell Therapy Ltd.100 enrolled11 locationsNCT04684147
Recruiting
Phase 1Phase 2
CD19 CAR-T Cell Infusion as Consolidation Therapy in Adolescent and Adult Patients With Acute B-ALL Ineligible for Allogeneic HSCT: A Clinical Study
Acute Lymphoblastic Leukemia
Zhujiang Hospital30 enrolled2 locationsNCT07072494
Recruiting
Not Applicable
JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia
B Acute Lymphoblastic LeukemiaB-Non Hodgkin Lymphoma
Affiliated Hospital of Guangdong Medical University20 enrolled1 locationNCT06940960
Recruiting
Phase 2Phase 3
Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol
Childhood Leukemia, Acute LymphoblasticB-cell Acute Lymphoblastic Leukemia (B-ALL)Acute Lymphoblastic Leukemia ALL
Institute of Hematology & Blood Diseases Hospital, China1,800 enrolled26 locationsNCT06764238
Recruiting
Phase 1
CD19/CD22 CAR-T Cell Therapy in MRD-Positive B-lineage Acute Lymphoblastic Leukemia in Children.
Acute Lymphoblastic Leukemia
Guangzhou Women and Children's Medical Center10 enrolled1 locationNCT06752785
Recruiting
Inaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic Leukemia
B-cell Acute Lymphoblastic Leukemia
Juventas Cell Therapy Ltd.200 enrolled10 locationsNCT06450067
Recruiting
Phase 2
A Single-arm, Open-label Study of Olverembatinib, CD3/CD19 Bispecific T-cell Engager, and Chidamide in Patients With Newly Diagnosed Ph+ALL
Acute Lymphoblastic LeukemiaAdult ALLPhiladelphia-Positive ALL+2 more
Nanfang Hospital, Southern Medical University67 enrolled1 locationNCT06220487